Concepedia

Hiroko Kuramochi

HK

Statistics

Publications

4

Citations

113

H-Index

4

Active since

2010

Affiliations

Eisai (Japan)(Current)

Hiroko Kuramochi is an author at Eisai (Japan) specializing in pharmacology, pharmacodynamics, and medicine.

Publications per year

2010–2016

4

Publications

4

The novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial thrombosis without affecting bleeding time in guinea pigs

Motoji Kogushi, Toshiyuki Matsuoka, Tsutomu Kawata et al. · European Journal of Pharmacology · 2011 · 48 citations

, , +14

E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models

Saori Watanabe Miyano, Yuji Yamamoto, Kotaro Kodama et al. · Molecular Cancer Therapeutics · 2016 · 37 citations · Full text

, , +16

Oral administration of the thrombin receptor antagonist E5555 (atopaxar) attenuates intimal thickening following balloon injury in rats

Motoji Kogushi, Toshiyuki Matsuoka, Hiroko Kuramochi et al. · European Journal of Pharmacology · 2011 · 18 citations

, , +7

E3710, a New Proton Pump Inhibitor, with a Long-Lasting Inhibitory Effect on Gastric Acid Secretion

Kotaro Kodama, Hideaki Fujisaki, Atsuhiko Kubota et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 10 citations

, , +17

1–4 of 4